Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Trends in Immunotherapy is Scopus-indexed (Q4, CiteScore 0.7). Published by UK Scientific Publishing Limited.
Checked against the index lists dated .
ISSN 2573-5985Verify ISSN ↗
Publisher: UK Scientific Publishing Limited
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 361 / 428 | 15th | Q4 |
| Pharmacology (medical) | 237 / 278 | 14th | Q4 |
| Immunology and Allergy | 209 / 234 | 10th | Q4 |
| Immunology | 227 / 243 | 6th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q4, CiteScore 0.7.
Trends in Immunotherapy is Q4 in Oncology (rank 361 of 428), Q4 in Pharmacology (medical) (rank 237 of 278) and Q4 in Immunology and Allergy (rank 209 of 234), by CiteScore 2025. It is ranked in 4 subject areas in all.
Trends in Immunotherapy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.7, quartile Q4, 15th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.167, quartile Q4, with an H-index of 6.
Trends in Immunotherapy is published by UK Scientific Publishing Limited. Its ISSN is 2573-5985.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Trends in Immunotherapy has an h-index of 9 and a 2-year mean of 0.74 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q4. On 2-year citations it ranks #309 of 424 Scopus journals in Oncology.
Trends in Immunotherapy published 61 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 41 research articles (2024–2026), authors are most often from India (18.3%), Indonesia (12.2%) and Iraq (9.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.